Purna appoints operations and quality directors after 2026 acquisition
AI Summary- Purna Pharmaceuticals appointed Wim Vanderaerden Operations Director and Bert Van Peteghem Quality Director and Qualified Person.
- Vanderaerden has over 20 years’ experience; Van Peteghem has more than 25 years.
- Ampersand Capital Partners acquired Purna in February 2026; Marc Verbruggen became Managing Director in June.